Tennessee 2023-2024 Regular Session

Tennessee Senate Bill SB1314

Caption

AN ACT to amend Tennessee Code Annotated, Title 53; Title 56; Title 63; Title 68 and Title 71, relative to medications intended for persons with diabetes.

Impact

The impact of SB1314 on state laws centers around prescribing authority and medical regulation. With the enactment of this bill, it may become more challenging for individuals without a diabetes diagnosis to receive medications that could aid in weight loss, thereby enforcing stricter standards on the use of certain medications. This could lead healthcare prescribers to exercise more caution in their prescription practices and ensure patients meet specific criteria, potentially affecting medication accessibility for those who may benefit from such drugs.

Summary

SB1314 is a piece of legislation aimed at regulating the prescription of dual-purpose medications intended for individuals with diabetes. Specifically, the bill amends multiple titles in the Tennessee Code Annotated, including Titles 53, 56, 63, 68, and 71, to establish a clear definition for 'dual-purpose prescription medication for diabetes.' These medications are defined as those that are indicated for diabetes management but may also be used for weight loss in individuals without diabetes. The legislation seeks to restrict healthcare prescribers from issuing prescriptions for these medications to patients who do not have a diabetes diagnosis.

Contention

One notable point of contention surrounding SB1314 could be the balance between the intended medical benefits of dual-purpose medications and potential misuse for weight loss. Critics of the bill could argue that restricting access to these medications may hinder some patients' treatment options. On the other hand, proponents may assert that the bill is necessary to prevent misuse of medications that are primarily intended for managing diabetes, thereby safeguarding public health and ensuring that these drugs remain effective for their intended patient population.

Companion Bills

TN HB1419

Crossfiled AN ACT to amend Tennessee Code Annotated, Title 53; Title 56; Title 63; Title 68 and Title 71, relative to medications intended for persons with diabetes.

Previously Filed As

TN HB1419

AN ACT to amend Tennessee Code Annotated, Title 53; Title 56; Title 63; Title 68 and Title 71, relative to medications intended for persons with diabetes.

TN SB1170

AN ACT to amend Tennessee Code Annotated, Title 4; Title 33; Title 49; Title 53; Title 55; Title 56; Title 63; Title 68 and Title 71, relative to healthcare professions.

TN HB1737

AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5, relative to insulin.

TN SB1683

AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5, relative to insulin.

TN HB0598

AN ACT to amend Tennessee Code Annotated, Title 32; Title 39; Title 56; Title 63 and Title 68, relative to vulnerable persons.

TN SB0640

AN ACT to amend Tennessee Code Annotated, Title 32; Title 39; Title 56; Title 63 and Title 68, relative to vulnerable persons.

TN HB2213

AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.

TN SB2361

AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.

TN HB0377

AN ACT to amend Tennessee Code Annotated, Title 8; Title 29; Title 33; Title 34; Title 56; Title 63; Title 68 and Title 71, relative to health care.

TN SB0585

AN ACT to amend Tennessee Code Annotated, Title 8; Title 29; Title 33; Title 34; Title 56; Title 63; Title 68 and Title 71, relative to health care.

Similar Bills

No similar bills found.